Close cardiovascular monitoring during the early stages of treatment for patients receiving immune checkpoint inhibitors

Source
Pharmaceuticals - ISSN 1424-8247-17:7 (2024) p. 1-12
Author(s)
    Danielle Delombaerde, Christof Vulsteke, Nico Van de Veire, Delphine Vervloet, Veronique Moerman, Lynn Van Calster, Anne-Marie Willems, Lieselot Croes, Felix Gremonprez, Astrid De Meulenaere, Ximena Elzo Kraemer, Kristien Wouters, Marc Peeters, Hans Prenen, Johan De Sutter

Extensive CArdioVAscular characterization and follow-up of patients receiving immune checkpoint inhibitors : a prospective multicenter study

Source
Pharmaceuticals - ISSN 1424-8247-16:4 (2023) p. 1-14
Author(s)
    Danielle Delombaerde, Johan De Sutter, Lieselot Croes, Delphine Vervloet, Veronique Moerman, Nico Van de Veire, Anne-Marie Willems, Kristien Wouters, Marc Peeters, Hans Prenen, Christof Vulsteke

First evidence of activity of enfortumab vedotin on brain metastases in urothelial cancer patients

Source
Pharmaceuticals - ISSN 1424-8247-16:3 (2023) p. 1-8
Author(s)
    Christof Vulsteke, Laurens De Cocker, Alfonso Gomez de Liano, Cristina Montesdeoca, Astrid De Meulenaere, Lieselot Croes, Danielle Delombaerde, Bernadett Szabados, Thomas Powles

Ipilimumab- and nivolumab-induced myocarditis in a patient with metastatic cholangiocarcinoma : a case report

Source
Journal of medical case reports - ISSN 1752-1947-16:1 (2022) p. 1-7
Author(s)
    Danielle Delombaerde, Delphine Vervloet, Dieter Berwouts, Roel Beckers, Hans Prenen, Marc Peeters, Félix Gremonprez, Lieselot Croes, Christof Vulsteke

POLRMT as a novel susceptibility gene for cardiotoxicity in epirubicin treatment of breast cancer patients

Source
Pharmaceutics - ISSN 1999-4923-13:11 (2021) p.
Author(s)
    Alejandro Velasco-Ruiz, Rocio Nunez-Torres, Guillermo Pita, Hans Wildiers, Diether Lambrechts, Sigrid Hatse, Danielle Delombaerde, Thomas Van Brussel, M. Rosario Alonso, Nuria Alvarez, Belen Herraez, Christof Vulsteke, Pilar Zamora, Teresa Lopez-Fernandez, Anna Gonzalez-Neira